Almost half of 9 and 10-year-olds get HPV vaccination at first opportunity This spring, more than 800,000 young people received an invitation to be vaccinated against HPV, the human papillomavirus.
Chromium-6 from medical implants not harmful to health Chromium-6 from medical implants, such as hip or knee implants, does not result in severe health damage.
Most reports received by MEBI in 2021 concerned copper IUDs More reports of suspected adverse effects from copper intrauterine devices (IUDs) were made in 2021 than in previous years, according to the annual report of the Dutch reporting and expertise centre for adverse effects of medical implants (MEBI).
Number of tuberculosis patients in the Netherlands increased slightly in 2021 compared to 2020 The number of people with tuberculosis (TB) in the Netherlands increased slightly in 2021, reaching 680. This figure is 9% higher than it was in 2020 (622 patients).
Shortcomings in the technical documentation of mesh implants intended to treat pelvic organ prolapse used in the Netherlands After a detailed assessment of the technical documentation of 9 different mesh implants intended to treat pelvic organ prolapse used in NL (2018) RIVM concludes that the safety and performance of these products were not properly substantiated.
Hardly any decrease in overweight, smoking and alcohol use since 2018 In 2021 half of all adults were overweight. 21% sometimes smoked, 7% were excessive drinkers and 8% heavy drinkers.
New criteria for amount of salt, sugar and saturated fat in foods The National Approach to Product Improvement (Nationale Aanpak Productverbetering, in Dutch NAPV) is set to start this year.
RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.
New: NEVO online 2021 RIVM published a new online edition of the Dutch food composition database (NEVO).
RIVM to play greater role in tuberculosis control The Committee for Practical Tuberculosis Control (CPT) will be transferred per 1 January 2022 to the National Institute for Public Health and the Environment (RIVM) after a period of 70 years with KNCV Tuberculosis Foundation.